Sergio Leal

Sergio Leal

Company: Bayer

Job title: Director, Global Clinical Leader Ophthalmology


Defining Visual Impairment and Clinically Relevant Endpoints in Intermediate AMD: The MACUSTAR Project 10:00 am

Identify hurdles for clinical development in intermediate AMD Learn about MACUSTAR, an IMI (Innovative Medicines Initiative) project aiming to characterize visual functional deficits, structural changes and longitudinal progression in early and intermediate AMD Discuss the industry perspective on the MACUSTAR project and its potential to support regulatory evaluations and patient access in intermediate AMDRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.